Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 3085390, 9 pages
http://dx.doi.org/10.1155/2016/3085390
Research Article

Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance

1Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950 Colonia Independencia, CP 44340, Guadalajara, JAL, Mexico
2Instituto de Investigación en Reumatología y del Sistema Musculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950 Colonia Independencia, CP 44340, Guadalajara, JAL, Mexico
3UDG-CA-701, Grupo de Investigación Inmunometabolismo en Enfermedades Emergentes (GIIEE), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950 Colonia Independencia, CP 44340, Guadalajara, JAL, Mexico
4Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Boulevard Marcelino García Barragán No. 1421, CP 44430, Guadalajara, JAL, Mexico
5Departamento de Disciplinas Filosófico, Metodológico e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950 Colonia Independencia, CP 44340, Guadalajara, JAL, Mexico
6UDG-CA-703, Grupo de Investigación en Inmunología y Reumatología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950 Colonia Independencia, CP 44340, Guadalajara, JAL, Mexico
7Translational Cardiology, Centre for Molecular Medicine, Department of Medicine, Karolinska Institutet, L8:03, 17176 Stockholm, Sweden
8Servicio de Reumatología, División de Medicina Interna, Hospital Civil “Dr. Juan I. Menchaca”, Universidad de Guadalajara, Salvador de Quevedo y Zubieta No. 750, CP 44340, Guadalajara, JAL, Mexico

Received 10 February 2016; Accepted 10 April 2016

Academic Editor: Jose C. Rosa

Copyright © 2016 Fernanda-Isadora Corona-Meraz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Makki, P. Froguel, and I. Wolowczuk, “Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines,” ISRN Inflammation, vol. 2013, Article ID 139239, 12 pages, 2013. View at Publisher · View at Google Scholar
  2. C. de Luca and J. M. Olefsky, “Inflammation and insulin resistance,” FEBS Letters, vol. 582, no. 1, pp. 97–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ye, “Mechanisms of insulin resistance in obesity,” Frontiers of Medicine, vol. 7, no. 1, pp. 14–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Wang and T. Nakayama, “Inflammation, a link between obesity and cardiovascular disease,” Mediators of Inflammation, vol. 2010, Article ID 535918, 17 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Chawla, K. D. Nguyen, and Y. P. S. Goh, “Macrophage-mediated inflammation in metabolic disease,” Nature Reviews Immunology, vol. 11, no. 11, pp. 738–749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Bourlier and A. Bouloumie, “Role of macrophage tissue infiltration in obesity and insulin resistance,” Diabetes & Metabolism, vol. 35, no. 4, pp. 251–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. McNelis and J. Olefsky, “Macrophages, immunity, and metabolic disease,” Immunity, vol. 41, no. 1, pp. 36–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Yao, O. Herlea-Pana, J. Heuser-Baker, Y. Chen, and J. Barlic-Dicen, “Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease,” Journal of Immunology Research, vol. 2014, Article ID 181450, 11 pages, 2014. View at Publisher · View at Google Scholar
  10. H. S. Schipper, B. Prakken, E. Kalkhoven, and M. Boes, “Adipose tissue-resident immune cells: key players in immunometabolism,” Trends in Endocrinology and Metabolism, vol. 23, no. 8, pp. 407–415, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. A. Zabel, M. Kwitniewski, M. Banas, K. Zabieglo, K. Murzyn, and J. Cichy, “Chemerin regulation and role in host defense,” American Journal of Clinical and Experimental Immunology, vol. 3, no. 1, pp. 1–19, 2014. View at Google Scholar
  12. M. C. Ernst and C. J. Sinal, “Chemerin: at the crossroads of inflammation and obesity,” Trends in Endocrinology and Metabolism, vol. 21, no. 11, pp. 660–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Bondue, V. Wittamer, and M. Parmentier, “Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism,” Cytokine and Growth Factor Reviews, vol. 22, no. 5-6, pp. 331–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Mariani and L. Roncucci, “Chemerin/chemR23 axis in inflammation onset and resolution,” Inflammation Research, vol. 64, no. 2, pp. 85–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Yoshimura and J. J. Oppenheim, “Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties,” Experimental Cell Research, vol. 317, no. 5, pp. 674–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Gayoso-Diz, A. Otero-González, M. X. Rodriguez-Alvarez et al., “Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study,” BMC Endocrine Disorders, vol. 13, article 47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Council for International Organizations of Medical Sciences and World Health Organization, International Ethical Guidelines for Epidemiological Studies, CIOMS, Geneva, Switzerland, 2009.
  18. M. Garaulet, J. J. Hernández-Morante, F. J. Tébar, S. Zamora, and M. Canteras, “Two-dimensional predictive equation to classify visceral obesity in clinical practice,” Obesity, vol. 14, no. 7, pp. 1181–1191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. NHANES, Anthropometry Procesures Manual, Edited by N.C.f.H. Statistics, CDC/National Center for Health Statistics, 2012.
  20. R. Ness-Abramof and C. M. Apovian, “Waist circumference measurement in clinical practice,” Nutrition in Clinical Practice, vol. 23, no. 4, pp. 397–404, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Zeng, Y. He, S. Dong et al., “Optimal cut-off values of BMI, waist circumference and waist: height ratio for defining obesity in Chinese adults,” British Journal of Nutrition, vol. 112, no. 10, pp. 1735–1744, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Amato, C. Giordano, M. Galia et al., “Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk,” Diabetes Care, vol. 33, no. 4, pp. 920–922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  24. T. M. Wallace and D. R. Matthews, “The assessment of insulin resistance in man,” Diabetic Medicine, vol. 19, no. 7, pp. 527–534, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Wintrobe and J. W. Landsberg, “A standardized technique for the blood sedimentation test 1935,” The American Journal of the Medical Sciences, vol. 346, no. 2, pp. 148–153, 2013. View at Google Scholar
  26. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  27. P. Chomczynski, “A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples,” BioTechniques, vol. 15, no. 3, pp. 532–537, 1993. View at Google Scholar · View at Scopus
  28. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M.-J. Lee, Y. Wu, and S. K. Fried, “Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications,” Molecular Aspects of Medicine, vol. 34, no. 1, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Fuentes, F. Fuentes, G. Vilahur, L. Badimon, and I. Palomo, “Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome,” Mediators of Inflammation, vol. 2013, Article ID 136584, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Guo, “Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms,” Journal of Endocrinology, vol. 220, no. 2, pp. T1–T23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. F. Johnson and J. M. Olefsky, “The origins and drivers of insulin resistance,” Cell, vol. 152, no. 4, pp. 673–684, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Herová, M. Schmid, C. Gemperle, and M. Hersberger, “ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 Macrophages,” The Journal of Immunology, vol. 194, no. 5, pp. 2330–2337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. C. Ernst, I. D. Haidl, L. A. Zuńĩga et al., “Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance,” Endocrinology, vol. 153, no. 2, pp. 672–682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Bondue, O. de Henau, S. Luangsay et al., “The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo,” PLoS ONE, vol. 7, no. 6, Article ID e40043, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Takahashi, Y. Okimura, G. Iguchi et al., “Chemerin regulates β-cell function in mice,” Scientific Reports, vol. 1, article 123, 2011. View at Publisher · View at Google Scholar
  37. Y. Suzuki, Y. H. Hong, S. H. Song et al., “The regulation of chemerin and CMKLR1 genes expression by TNF-α, adiponectin, and chemerin analog in bovine differentiated adipocytes,” Asian-Australasian Journal of Animal Sciences, vol. 25, no. 9, pp. 1316–1321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Takahashi, Y. Takahashi, K. Takahashi et al., “Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes,” FEBS Letters, vol. 582, no. 5, pp. 573–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. K. B. Goralski, T. C. McCarthy, E. A. Hanniman et al., “Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism,” The Journal of Biological Chemistry, vol. 282, no. 38, pp. 28175–28188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Adrych, M. Stojek, M. Smoczynski, T. Sledzinski, S.-W. Sylwia, and J. Swierczynski, “Increased serum chemerin concentration in patients with chronic pancreatitis,” Digestive and Liver Disease, vol. 44, no. 5, pp. 393–397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Neuparth, J. B. Proença, A. Santos-Silva, and S. Coimbra, “The positive effect of moderate walking exercise on chemerin levels in portuguese patients with type 2 diabetes mellitus,” Journal of Investigative Medicine, vol. 62, no. 2, pp. 350–353, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Miehle, T. Ebert, S. Kralisch et al., “Circulating serum chemerin levels are elevated in lipodystrophy,” Clinical Endocrinology, 2015. View at Publisher · View at Google Scholar
  43. H. Lórincz, M. Katkõ, M. Harangi et al., “Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects,” Clinical Endocrinology, vol. 81, no. 3, pp. 370–377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. P. H. Dessein, L. Tsang, A. J. Woodiwiss, G. R. Norton, and A. Solomon, “Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis,” Journal of Rheumatology, vol. 41, no. 9, pp. 1746–1754, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Fülöp, I. Seres, H. Lorincz, M. Harangi, S. Somodi, and G. Paragh, “Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients,” Journal of Cellular and Molecular Medicine, vol. 18, no. 7, pp. 1313–1320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Cheng and C. Daskalakis, “Association of adipokines with insulin resistance, microvascular dysfunction, and endothelial dysfunction in healthy young adults,” Mediators of Inflammation, vol. 2015, Article ID 594039, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus